Mohammed Haseebuddin, MD

Articles by Mohammed Haseebuddin, MD

Dr. Mohammed Haseebuddin on Expanding Role for Immunotherapy in RCC

November 3rd 2016

Mohammed Haseebuddin, MD, a fellow in Urologic Oncology at Fox Chase Cancer Center, discuses why continued research into immunotherapy in clear cell renal cell carcinoma (RCC) is important, particularly in the adjuvant and neoadjuvant settings.

Dr. Mohammed Haseebuddin on PD-1 Expression in RCC

ByMohammed Haseebuddin, MD

August 17th 2016

Dr. Haseebuddin on PD-1 Expression on Monocytes in RCC

ByMohammed Haseebuddin, MD

July 21st 2016

Mohammed Haseebuddin, MD, a fellow in Urologic Oncology at Fox Chase Cancer Center, discusses the overall significance of a study examining an elevated preoperative classical monocyte PD-1 mean fluorescence intensity level in patients with clear cell renal cell carcinoma.